Completed PHASE1 INTERVENTIONAL 2-arm NCT03439527

Multisystem Cell Therapy for Improvement of Urinary Continence (MUSIC)

Open-label, Monocentric, First-in-man Trial to Assess Safety and Tolerability of a New Therapeutic Strategy for Stress Urinary Incontinence Based on the Implantation of Muscle Precursor Cells (MPCs)

Sponsor: Salzburger Landeskliniken

Conditions Urinary Stress Incontinence

Interventions Muscle Precursor Cells (MPCs), ATMP

Updated 9 times since 2018 Last updated: Nov 2, 2021 Started: Jan 22, 2020 Primary completion: Sep 3, 2021 Completion: Oct 21, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Urinary Stress Incontinence and is currently completed. Salzburger Landeskliniken leads this study, which shows 9 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Dec 2021 — Jul 2024 [monthly]

Completed PHASE1

Status: Active Not Recruiting → Completed
Oct 2021 — Dec 2021 [monthly]

Active Not Recruiting PHASE1

Status: Recruiting → Active Not Recruiting

▶ Show 4 earlier versions

Jan 2021 — Oct 2021 [monthly]

Recruiting PHASE1
Feb 2020 — Jan 2021 [monthly]

Recruiting PHASE1

Status: Not Yet Recruiting → Recruiting
Jun 2018 — Feb 2020 [monthly]

Not Yet Recruiting PHASE1
Mar 2018 — Jun 2018 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Salzburger Landeskliniken
University Hospital Tuebingen
University of Zurich

Data source: University of Zurich

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zurich, Switzerland